Clinical Trial Search

Primary: Visual Analog Scale (VAS) — 7.47; 7.97 units on a scale

Primary: Patient Scar Satisfaction Scale Score — 13; 13.5 score on a scale

Primary: Number of Participants With Complication of Wound Dehiscence — 0; 0 participants

Primary: Stony Brook Scar Evaluation Scale — 2.8; 4.09; 3.45 score on a scale

Primary: Number of Participants With Wound Complications (Surgical Site Infection (SSI), Hematoma, Separation, Seroma, Etc) — 23; 37; 16; 25 Participants — p=0.04

Primary: Scar Quality at 6 Months Postoperative — 3.8; 2.6 units on a scale

Primary: Number of Participants Who Develop Contact Dermatitis — 21; 18 Participants

Primary: Wound Healing by Numerical Scales for Rubor Postoperative Day 2. — 0.516; 0.984 units on a scale

Primary: Scar Appearance — 7; 2.33 score on a scale

Primary: Continuous Apposition of the Skin Edges Without Wound Dehiscence or Re-closure as Measured by the Upper Limit of 95% Confidence Interval in Proportion of Successes for…

Primary: Number of Participants With Wound Closure — 8 participants

Primary: Number of Participants With Wound Disruption or Infection (Wound Complications) Occurring Within 4-8 Weeks of the Date of the Primary Surgery. — 28; 25 Participants

Primary: Number of Participants With Wound Complications — 18; 40; 9; 14 Participants

Primary: Total Dermal Closure Time — 12; 19.2 Minutes

Primary: Patient Observer Scar Assessment Score (POSAS) — 20; 21 score on a scale — p=0.481

Primary: Level of Pain on a Scale During the Post-operative Hospitalization Period — 2.0; 2.0 units on a scale — p=0.60

Primary: Vaginal Cuff Closure Time — 10.4; 9.6 minutes

Primary: Overall Closure Time — 78; 216 seconds — p=<0.001

Primary: Total Surgical Time, All Resident Levels — 58.0; 54.0 minutes — p=0.053

Primary: Presence of Scarring — 1; 1 participants

Primary: Placenta Previa — 18; 17; 0; 3 Participants

Primary: Cesarean Scar Defect in the Uterine Incisional Line — 12; 39 participants — p=0.0001

Primary: Comparison of the Total Cost of Wound Closure When Using Dermabond PRINEO Versus the Surgeon's Control. — 627.83; 304.75; 568.53; 420.77 Dollars

Primary: Incision Appearance / Scar Cosmesis — 1.3; 2.6; 1.9; 3.3 units on a scale

Primary: Evaluation of the Difference Between the Groups in the Number of Patients With Wound Infection at the End of the 10th Postoperative Day — 80; 90; 93; 12 Participants

Primary: Composite Wound Complication at Hospital Discharge and 2 Weeks Postpartum — 8; 5; 15; 16 Participants

Primary: Time of Closure in Minutes — 36.3; 31.1; 35.9; 27.1 minutes

Primary: Continuous Apposition of the Skin Edges Without Wound Dehiscence or Re-closure as Measured by the Upper Limit of 95% Confidence Interval in Proportion of Successes for…

Primary: Operative Time — 35; 423 seconds

Primary: Incisional Hernia — 32; 38 participants — p=0.60